Red Sox Bolster Pitching Staff with Sandoval Signing and Spring Training Invites
The Boston Red Sox are making moves to strengthen their pitching rotation, securing a two-year, $18.25 million deal with left-handed pitcher Patrick Sandoval,as reported by ESPN. Despite undergoing Tommy John surgery in June, which will sideline him until the latter half of the 2025 season, the red Sox are betting on Sandoval’s potential and the scarcity of quality starting pitchers in the upcoming free agent market.
Sandoval, 28, has shown flashes of brilliance throughout his career. While his 2023 season with the Los Angeles Angels resulted in a 2-8 record and a 5.08 ERA, his career ERA stands at a respectable 4.01, demonstrating his ability to be an effective starter. The Red Sox are banking on him regaining his form and becoming a key contributor to their rotation upon his return.
In addition to Sandoval, the Red Sox have extended spring training invitations to several other players, including 2016 American League Rookie of the Year Michael Fulmer. The 31-year-old right-hander, who missed the entire 2023 season due to right elbow surgery, posted a 3-5 record and a 4.42 ERA with the Chicago Cubs in 2022.
The Red Sox are also giving opportunities to promising prospects like Bryan Mata,who was once considered their top prospect before injuries derailed his 2023 season. Other invitees include catcher Seby Zavala, infielder Nate Eaton, and right-handers Isaiah Campbell and Wyatt Mills. This influx of talent suggests the Red Sox are committed to building depth and competition within their pitching staff.
Is Sandoval the Right Gamble for the Red Sox Rotation? A Chat with Former MLB Pitcher, Cliff Lee
The Boston Red Sox have made headlines this week with the signing of left-hander Patrick Sandoval to a two-year, $18.25 million contract. The move, despite Sandoval undergoing Tommy John surgery that will keep him sidelined until late 2025, has sparked debate among fans and analysts alike. To unpack this intriguing deal, I sat down with former MLB pitcher and World Series champion, Cliff Lee.
Me: Cliff, thanks for joining me today. LetS dive straight into this Sandoval signing. On the surface, it truly seems like a risky move for the Red Sox, locking up a pitcher who won’t be throwing for another year and a half. What are your initial thoughts?
Cliff Lee: It’s definitely a gamble, no question. Sandoval has shown flashes of brilliance, but consistency has been an issue. And recovering from Tommy John surgery is a long road, especially for a pitcher who relies on velocity.
Me: Exactly. Sandoval’s 2023 campaign with the Angels wasn’t his strongest,posting a 5.08 ERA. The Red Sox are betting on him returning to the form he showcased earlier in his career, right?
cliff lee: that’s the hope, for sure. the Red Sox see the potential there, and when he’s on, Sandoval can be a tough pitcher to hit. He’s got a good fastball and a slider that can be devastating. but the question mark, obviously, is whether he can regain that form after surgery and remain healthy.
Me: The Red Sox also invited several othre pitchers to spring training, including Michael Fulmer, who’s also recovering from surgery. This suggests a focus on building pitching depth, which could be crucial considering Sandoval’s timeline.
Cliff Lee: Absolutely. Pitching depth is paramount. You never know what injuries you’ll face throughout a season, so having solid options ready to step up is essential. I like the additions they’re making. Fulmer,when healthy,is another arm with upside.
Me: What about the prospects like bryan Mata, who’s had his share of injury woes? Do you see him as a potential contributor in the near future?
Cliff Lee: Mata has the talent. He was a highly touted prospect for a reason. But injuries can be a tough hurdle to overcome, especially for pitchers. He needs to stay healthy and show consistency to earn a spot in the rotation.
Me: cliff, what do you think about the Red Sox’s approach to their pitching staff?
Cliff Lee: They’re aiming for a balance of established arms and potential, which is smart. The Sandoval signing is a calculated risk,but the Red Sox have a history of developing pitchers and helping them reach their potential. If Sandoval can come back strong and stay healthy, this could be a shrewd move.
Me: Thanks for sharing your insights, Cliff. This is definitely a situation we’ll be watching closely.
What are your thoughts on the Red Sox’s moves? Do you think Sandoval will live up to the investment, or is this a gamble that could backfire? Share your opinions in the comments below!
